Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
Reports describe recent advances in ovarian cancer research
September 15th, 2005
Data on ovarian cancer are outlined in reports from the United States and United Kingdom. Study 1: Weekly paclitaxel therapy proves effective against ovarian cancer. Researchers at the University of North Carolina conducted a study "To determine the impact of weekly paclitaxel consolidation on progress ion-free survival (PFS) of women undergoing treatment for ovarian cancer. All women with advanced epithelial ovarian or primary peritoneal carcinoma, treated with paclitaxel consolidation therapy from August 1997 to March 2002, were identified." "Patients received weekly paclitaxel infused at a median dose of 80 mg/m2...
Source: Women's Health Weekly (2005-09-15)
|
